z-logo
open-access-imgOpen Access
FORMULATION AND EVALUATION OF MEFENAMIC ACID OINTMENT USING PENETRATION ENHANCERS
Author(s) -
Yousaf Khan,
Syed Umer Jan,
Rahman Gul
Publication year - 2020
Publication title -
international journal of current pharmaceutical research
Language(s) - English
Resource type - Journals
ISSN - 0975-7066
DOI - 10.22159/ijcpr.2020v12i6.40306
Subject(s) - mefenamic acid , oleic acid , chemistry , differential scanning calorimetry , chromatography , permeation , pulmonary surfactant , penetration (warfare) , active ingredient , nuclear chemistry , pharmacology , membrane , medicine , biochemistry , mathematics , physics , operations research , thermodynamics
Objective: The aim of study was to formulate and evaluate Mefenamic acid ointment by the addition of penetration enhancer’s clove oil. Methods: 1%, 2% and 3% formulations of Mefenamic acid ointment formulated as per B. P, by melting hard paraffin 4.75g at 60 °C initially and to this 4.75 g wool fatwas incorporated, followed by addition of soft paraffin 80.75g and then adding Cetostearyl alcohol 4.75g and 1,2 and 3 ml clove oil by continuous stirring later on ointment being cooled at room temperature. These formulations were checked for consistency, Spreadability, homogeneity, PH, viscosity, skin irritation, drug content, UV absorbance, Differential scanning calorimetry (DSC) and XRD (X. ray diffraction) studies. In vitro pattern via using Franz cells besides with the use of dialysis cellulose membrane was done. Results: All the synthesized formulations illustrated fine physicochemical characteristics. SEM and XRD Studies expressed that there were no physicochemical incompatibilities among active ingredient (Mefenamic acid salt) and additives combined as drug permeation enhancers (clove oil).3% formulation showed maximum released 65.199%. Conclusion: In the present study, it was noted that clove oil can enhance the permeation of Mefenamic acid topical ointment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here